Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma
Yutaka Suehiro, Chi Wai Wong, Lucian R Chirieac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results
Hagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
The Lancet. Oncology
|
August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Hagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Genome Biology
|
November 27, 2019
DNA methylation aging clocks: challenges and recommendations
Christopher G Bell, Robert Lowe, Peter D Adams, et al.
Science Translational Medicine
|
March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Thushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Blood Advances
|
June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Blood
|
May 4, 2022
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy
Amer M Zeidan, Pierre Fenaux, Marco Gobbi, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.
Cancer Discovery
|
April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers
Curtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.
Blood Neoplasia
|
June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma
Yutaka Suehiro, Chi Wai Wong, Lucian R Chirieac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results
Hagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
The Lancet. Oncology
|
August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Hagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Genome Biology
|
November 27, 2019
DNA methylation aging clocks: challenges and recommendations
Christopher G Bell, Robert Lowe, Peter D Adams, et al.
Science Translational Medicine
|
March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Thushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Blood Advances
|
June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Blood
|
May 4, 2022
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy
Amer M Zeidan, Pierre Fenaux, Marco Gobbi, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.
Cancer Discovery
|
April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers
Curtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.
Blood Neoplasia
|
June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS
H Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.
Page
of 21